Remodulin News
Most Popular Remodulin Story
Decision delayed on United Therapeutics' Tyvaso
After scrambling to come up with new data on the experimental hypertension drug Tyvaso, United Therapeutics says it will now have to wait a few more months before it gets a decision from the FDA. The Read more...
Latest Headlines
- April 29, 2009
- November 17, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
